{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:30:45Z","timestamp":1795026645872,"version":"4.10.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to compare Thromboelastographic (TEG) profiles and clinical characteristics between severe Mycoplasma pneumoniae (MP) pneumonia patients with normal and abnormal TEG parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical data of 133 children with severe MP pneumonia were retrospectively analyzed. Patients were divided into normal (<jats:italic>n<\/jats:italic>\u2009=\u200976) and abnormal (<jats:italic>n<\/jats:italic>\u2009=\u200957) TEG groups. Demographic characteristics, clinical manifestations, laboratory findings, imaging features, bronchoscopy results, treatment, complications, and outcomes were compared between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The abnormal TEG group (42.9%) had longer fever duration (median: 8.5 vs. 7.0 days, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001) and hospital stay (median: 11.5 vs. 10.0 days, <jats:italic>P<\/jats:italic>\u2009=\u20090.003). They also showed higher levels of C-reactive protein (median: 30.2 vs. 20.1\u2005mg\/L, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), lactate dehydrogenase (median: 334.5 vs. 276.0\u2005U\/L, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), and D-dimer (median: 1.2 vs. 0.5\u2005\u03bcg\/ml, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001). HRCT revealed more lobar consolidation or multilobar involvement (36.8% vs. 18.4%, <jats:italic>P<\/jats:italic>\u2009=\u20090.016), and bronchoscopy showed more mucous plug obstruction (28.1% vs. 10.5%, <jats:italic>P<\/jats:italic>\u2009=\u20090.008) in the abnormal TEG group. TEG parameters indicated a hypercoagulable state with shorter R time (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), shorter K time (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), and higher MA (<jats:italic>P<\/jats:italic>\u2009=\u20090.003). The abnormal TEG group had higher incidences of coagulopathy (<jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001), cardiac involvement (elevated cardiac enzymes: 36.8% vs. 17.1%, <jats:italic>P<\/jats:italic>\u2009=\u20090.009; pericardial effusion: 10.5% vs. 1.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.017), and plastic bronchitis (<jats:italic>P<\/jats:italic>\u2009=\u20090.006). They also required longer azithromycin courses (median: 15 vs. 14 days, <jats:italic>P<\/jats:italic>\u2009=\u20090.026).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Children with severe MP pneumonia and abnormal TEG profiles have more severe clinical manifestations, higher inflammatory markers, more extensive lung involvement, and a higher incidence of complications. TEG may help identify high-risk patients and guide management in severe MP pneumonia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1459455","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:13:20Z","timestamp":1737530000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of thromboelastographic profiles and clinical characteristics in children with severe Mycoplasma pneumoniae pneumonia"],"prefix":"10.3389","volume":"13","author":[{"given":"Yong-tao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-li","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103863","DOI":"10.1016\/j.micpath.2019.103863","article-title":"Mycoplasma pneumoniae-related hepatitis in children","volume":"139","author":"Poddighe","year":"2020","journal-title":"Microb Pathog"},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","article-title":"Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019","volume":"120","author":"Lee","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"687391","DOI":"10.3389\/fcimb.2021.687391","article-title":"The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zheng","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jpedsurg.2022.01.059","article-title":"Use of thromboelastography in children on extracorporeal membrane oxygenation","volume":"57","author":"Wagner","year":"2022","journal-title":"J Pediatr Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00134-014-3552-9","article-title":"Thromboelastography in patients with severe sepsis: a prospective cohort study","volume":"41","author":"Haase","year":"2015","journal-title":"Intensive Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12032-008-9129-0","article-title":"Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography","volume":"26","author":"Akay","year":"2009","journal-title":"Med Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3760\/cma.j.cn331340-20230217-00023","article-title":"Guidelines for the diagnosis and treatment of Mycoplasma pneumonia in children (2023 edition)","volume":"50","year":"2023","journal-title":"Int J Epidemiol Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.issn.1674-2397.2019.01.002","article-title":"Standards for diagnosis and treatment of community-acquired pneumonia in children (2019 edition)","volume":"12","year":"2019","journal-title":"Chin J Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/jcm11102824","article-title":"Refractory Mycoplasma pneumoniae pneumonia in children: early recognition and management","volume":"11","author":"Tong","year":"2022","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.rpth.2022.100031","article-title":"Viscoelastic testing: an illustrated review of technology and clinical applications","volume":"7","author":"Hartmann","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjh.17172","article-title":"Disseminated intravascular coagulation: epidemiology, biomarkers, and management","volume":"192","author":"Adelborg","year":"2021","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2010024","DOI":"10.4084\/mjhid.2010.024","article-title":"Sepsis-associated disseminated intravascular coagulation and thromboembolic disease","volume":"2","author":"Semeraro","year":"2010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40560-023-00672-5","article-title":"The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation","volume":"11","author":"Iba","year":"2023","journal-title":"J Intensive Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2119\/molmed.2009.00091","article-title":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","volume":"15","author":"Milbrandt","year":"2009","journal-title":"Mol Med"},{"key":"B18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-3-030-54924-4_23","article-title":"Plastic Bronchitis. In: Goldfarb S, Piccione J, editors","volume-title":"Diagnostic and Interventional Bronchoscopy in Children. Respiratory Medicine","author":"Davis","year":"2021"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1542\/pir.2018-0016","article-title":"Mycoplasma pneumonia in children and adolescents","volume":"41","author":"Krafft","year":"2020","journal-title":"Pediatr Rev"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1459455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:13:26Z","timestamp":1737530006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1459455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":19,"alternative-id":["10.3389\/fped.2025.1459455"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1459455","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"article-number":"1459455"}}